Cravath Publishes Winter 2026 Issue of Alumni Journal
November 01, 2008
On October 31, 2008, the New York Supreme Court, Commercial Division, denied Hexion Specialty Chemicals, Inc.’s motion for a temporary restraining order and a preliminary injunction against Cravath’s clients, Credit Suisse and Deutsche Bank. Hexion sued the two banks on October 29, 2008, seeking to postpone the expiration of the banks’ commitment letter that provided for the financing of the proposed merger between Hexion and Huntsman Corporation. The commitment letter expired by its terms on November 1, 2008. Hexion claimed that the banks breached the commitment letter, which they entered into, subject to certain conditions, in July 2007.
Justice Eileen Bransten denied Hexion’s motion, holding that Hexion was not entitled to injunctive relief because it had not demonstrated irreparable harm or a probability of success on the merits of its breach of contract claim and because the equities weighed in favor of the banks. Justice Bransten held that the banks were entitled to have the court enforce the commitment letter, including its expiration provisions, as written and bargained for by the parties.
This was the third time in as many weeks that the Cravath team defeated attempts made by Hexion or Huntsman in three different courts to prevent or extend the expiration of the commitment letter. The Cravath attorneys involved in this matter include partners Richard W. Clary, Robert H. Baron, Julie A. North and Gary A. Bornstein, senior attorney Lillian S. Grossbard and associates Martin J. Crisp, Jonathan M. Watkins, Misty L. Archambault, William B. Brady, Lauren P. Rubin, Isaac B. Zaur, Edward A. Imperatore, Erin C. Trenda and Benjamin R. Rossen.
Deals & Cases
February 20, 2026
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 27, 2026
Cravath represented the European Investment Bank (“EIB”) in connection with its $6 billion SEC registered notes offering. The purpose of the EIB is to contribute to the balanced and steady development of the internal market among Member States of the European Union. The notes were listed on the Luxembourg Stock Exchange. The transaction closed on January 13, 2026.
Deals & Cases
January 08, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 24, 2025
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.